Patents by Inventor Mary K. Short

Mary K. Short has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mitochondrial inhibitors to treat human disease
    Patent number: 8581005
    Abstract: The present invention relates to inhibitors of mitochondria-associated, granulocyte-macrophage colony stimulating factor signaling molecule (Magmas), and related compositions and uses thereof.
    Type: Grant
    Filed: March 16, 2010
    Date of Patent: November 12, 2013
    Assignee: Albert Einstein College of Medicine of Yeshiva University
    Inventors: Paul Jubinsky, Bhaskar C. Das, Mary K. Short
  • MITOCHONDRIAL INHIBITORS TO TREAT HUMAN DISEASE
    Publication number: 20120093728
    Abstract: The present invention relates to inhibitors of mitochondria-associated, granulocyte-macrophage colony stimulating factor signaling molecule (Magmas), and related compositions and uses thereof.
    Type: Application
    Filed: March 16, 2010
    Publication date: April 19, 2012
    Inventors: Paul Jubinsky, Bhaskar Chandra Das, Mary K. Short
  • Antibodies to MAGMAS and uses thereof
    Publication number: 20090155172
    Abstract: The present invention relates to isolated and purified Magmas protein, isolated and purified nucleic acids encoding Magmas protein, and antibodies to Magmas protein, which interacts with granulocyte macrophage colony stimulating factor (GM-CSF). More specifically, the invention relates to uses of such anti-Magmas antibodies. The invention further relates to a method for diagnosis, prognosis and treatment of diseases, particularly, cancer, Alzheimer's disease and mitochondrial diseases using Magmas sequences and antibodies directed against the Magmas protein or fragments thereof.
    Type: Application
    Filed: January 26, 2008
    Publication date: June 18, 2009
    Inventors: Mary K. Short, Paul T. Jubinsky
  • Antibodies to magmas and uses thereof
    Patent number: 7358041
    Abstract: The present invention relates to isolated and purified Magmas protein, isolated and purified nucleic acids encoding Magmas protein, and antibodies to Magmas protein, which interacts with granulocyte macrophage colony stimulating factor (GM-CSF). More specifically, the invention relates to uses of such anti-Magmas antibodies. The invention further relates to a method for diagnosis, prognosis and treatment of diseases, particularly, cancer, Alzheimer's disease and mitochondrial diseases using Magmas sequences and antibodies directed against the Magmas protein or fragments thereof.
    Type: Grant
    Filed: December 2, 2002
    Date of Patent: April 15, 2008
    Inventors: Mary K. Short, Paul T. Jubinsky